We've updated our Privacy Policy to make it clearer how we use your personal data.

We use cookies to provide you with a better experience, read our Cookie Policy

Phase I Clinical Trial Completes Using Cell Line Expertise at Cobra Biologics

News   Apr 03, 2017 | Original story from Cobra Biologics

 
Phase I Clinical Trial Completes Using Cell Line Expertise at Cobra Biologics

Peter Coleman, CEO of Cobra Biologics

 
 
 

RELATED ARTICLES

Hat Could One Day Reverse Baldness – And It's Cheap Too!

News

Few things on earth strike fear into the hearts of men more profoundly than hair loss. But reversing baldness could someday be as easy as wearing a hat, thanks to a noninvasive, low-cost hair-growth-stimulating technology developed by engineers at the University of Wisconsin–Madison.

READ MORE

Wetland Microbe Could Help in Contaminant Clean-up

News

Researchers have identified bacteria from a New Jersey wetland that, surprisingly, can break carbon-fluorine bonds and degrade PFAS.

READ MORE

A Cure for the Common Cold?

News

Disabling a single, apparently noncritical protein in cells may foil replication of the viruses that cause half of all common colds, polio and other diseases.

READ MORE

 

Like what you just read? You can find similar content on the communities below.

Analysis & Separations Drug Discovery Immunology & Microbiology

To personalize the content you see on Technology Networks homepage, Log In or Subscribe for Free

LOGIN SUBSCRIBE FOR FREE